Cosmo Bio

Cosmo Bio

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10.3M

Overview

Cosmo Bio USA, founded in 2004 and headquartered in Carlsbad, California, operates as a niche distributor in the life sciences sector, specializing in diagnostics and antibody-related reagents. The company differentiates itself through exclusive partnerships with over 70 Japanese manufacturers and select international innovators, providing U.S. and global researchers with difficult-to-source products. It generates revenue by selling these curated reagents and offers value-added services like personalized scientific support and import logistics assistance. As a private, revenue-generating entity, it serves as a critical bridge between specialized manufacturers and the research community.

DiagnosticsAntibodies

Technology Platform

A curated distribution and scientific support ecosystem providing exclusive access to specialized life science reagents from a global network (primarily Japanese) of manufacturers, combined with expert technical guidance and logistics management.

Funding History

2
Total raised:$10.3M
Series A$8.5M
Seed$1.8M

Opportunities

Capitalizing on the growing demand for specialized, hard-to-find research tools, particularly those from innovative Japanese manufacturers, in the large North American life science market.
The trend towards outsourcing and the need for expert technical support in complex research areas like extracellular vesicles and synthetic biology presents a significant growth avenue.

Risk Factors

High dependence on a concentrated supplier base in Japan creates supply chain vulnerability.
Intense competition from large, broad-line distributors who could replicate its partnership model or compete on price and logistics poses a constant threat.

Competitive Landscape

Operates in a niche segment of the highly competitive life science distribution market, dominated by global giants like Thermo Fisher Scientific and Merck. Its differentiation lies in exclusive access to Japanese innovations and personalized scientific support, competing on specialization and expertise rather than catalog breadth or scale.